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Um eletrodo compósito de grafite-poliuretana sem modificação foi avaliado como um detector 
amperométrico para análise em fluxo, na determinação de paracetamol (APAP) em formulações 
farmacêuticas. Uma curva analítica foi obtida com região linear entre 5,00 x 10-5 e 5,00 x 10-3mol L-1,
com um limite de detecção de 18,9 Mmol L-1 e 180 determinações por hora, depois de parâmetros 
otimizados como potencial de detecção, volume de amostragem, e vazão da solução carregadora. 
Interferência de ácido ascórbico foi observada, entretanto foi possível contorná-la, como visto 
pelos resultados que concordaram com HPLC com nível de confiança de 95%. Estes resultados 
mostraram que o compósito grafite-poliuretana pode ser usado como um detector amperométrico 
para análise em fluxo na determinação de APAP.
A bare graphite-polyurethane composite was evaluated as an amperometric flow injection 
detector in the determination of paracetamol (APAP) in pharmaceutical formulations. A linear 
analytical curve was observed in the 5.00 x 10-5 to 5.00 x 10-3 mol L-1 range with a minimum 
detectable net concentration of 18.9 Mmol L-1 and 180 determinations h-1, after optimization of 
parameters such as the detection potential, sample loop volume, and carrier solution flow rate. 
Interference of ascorbic acid was observed, however, it was possible overcome the interference, 
reaching results that agreed with HPLC within 95% confidence level. These results showed that 
the graphite-polyurethane composite can be used as an amperometric detector for flow analysis 
in the determination of APAP.
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Introduction
Paracetamol (N-acetyl-p-aminophenol, acetaminophen, 
APAP) had been used for a long time and is one of the most 
extensively employed drugs in the world. It was first used 
in medicine by von Mering in 1893. However, it was first 
discovered to have both analgesic and antipyretic properties 
in the late 19th century. APAP is the active ingredient of 
several pharmaceutical products, in different dosage forms 
and doses, alone or in association. It is a suitable alternative 
for the patients who are sensitive to aspirin and safe up to 
therapeutic doses.1
It has low toxicity when used at the recommended 
doses.2 Nevertheless, the ease with which the general public 
can access this drug makes it frequently associated with 
overdoses, in this situation causing serious or even fatal 
hepatic damage.3 The treatment of a supposed overdose 
of APAP demands a rapid and reliable determination of its 
concentration in blood serum. So, APAP and its metabolites 
have been extensively investigated.4
Several analytical techniques such as titrimetry,5
spectrophotometry,6,7 spectrofluorometry,8 colorimetry,9
HPLC,10,11 and many other methods are proposed for 
the determination of APAP. Electrochemical methods, 
especially the voltammetric and amperometric ones gave 
the opportunity to study the oxidation mechanisms. The 
cyclic voltammetric study concerning the electrochemical 
oxidation of APAP was described in the work of Kissinger 
et al.12
Since voltammetric techniques are more selective, less 
costly and less time-consuming, they are widely used for 
the determination of APAP in pharmaceutical formulations 
and body fluids. Voltammetric determinations of APAP at 
chemically modified electrodes,13 glassy carbon electrode,14
platinum electrode,15 and at other electrodes16 have been 
described.
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On the other hand, flow injection analysis (FIA) has 
been used routinely since its inception to provide sample 
handling automated control.17 FIA involves the injection 
of a reproducible sample volume into a continuous flowing 
unsegmented carrier solution, followed by quantification 
at a detector device. In addition to automated control, FIA 
offers other advantages. These include convective mass 
transport, matrix exchange, and increased precision. The 
combination of FIA with electrochemical detection is 
attractive because of the flexibility of the former and the 
diagnostic power of the latter.18,19
In order to join the advantages of both FIA and 
voltammetric techniques, an electrode suitable to use under 
hydrodynamic conditions is necessary. We have recently 
proposed the use of a graphite-polyurethane composite as 
an electrode material that is inexpensive, long life, easy to 
prepare, and that can be used over a wide range of potentials 
and pH. We also found that for non-adsorbent analytes the 
electrode did not require frequent surface renewing and 
operates as an amperometric sensor in flow systems.20-22
Recently an extensive review on methods for 
determination of APAP was presented by Espinosa and co-
workers.23 In that paper is possible to note that although flow 
injection procedures with spectrophotometric detection and 
several electroanalytical methods have been described for 
APAP detection, few works on direct determination in an 
amperometric flow injection system is described. An other 
remarkable fact is that with the graphite polyurethane 
composite electrode the detection potential can be lowered 
down to 0.5 (vs. Ag/AgCl).
This work describes the optimization of a flow injection 
system with electrochemical detection for the determination 
of APAP in pharmaceutical formulations, using a 60% 
(m/m) graphite-polyurethane (PU) composite electrode as 
an amperometric detector in a flow injection procedure. 
Experimental
Apparatus
All the reference or sample solutions were injected 
manually into the carrier stream using a laboratory-
constructed three-piece injector-commutador made of 
polymethylmethacrylate (PMMA),24 with two fixed side bars 
and a sliding central bar, which is moved for sampling and 
injection. The solutions were conducted with polyethylene 
tubing (0.8 mm i.d, Fiotubos, Brazil) and propelled with an 
IPC 8-channel peristaltic (Ismatec, Swtizerland) pump. An 
illustration of such system is presented in Figure 1. 
Potentials were measured with an AUTOLAB 
PGSTAT-30 (Ecochemie, The Netherlands) potentiostat/
galvanostat coupled to a personal computer and controlled 
with a GPES 4.9 software. The measurements were 
performed in a three-electrode configuration flow cell 
(details in Figure 1) using the graphite-PU composite 
electrode 60% (graphite, m/m) or a glassy carbon (GC) 
as working electrodes. An Ag/AgCl, KCl 0.1 mol L–1 was 
used as reference and a platinum disk ( = 3mm) was a 
counter electrode.
The body of the electrochemical flow cell (details in 
Figure 1) was fabricated with an unmodified castor oil 
polyurethane resin (Poliquil, Brazil) with an effective 
volume of 25 µL.20
Reagents and solutions 
Solutions were prepared with twice distilled water in 
a quartz stiller. The APAP used was of analytical reagent 
grade (Natural Pharma, Brazil). Stock 5.00 mmol L-1 APAP 
in universal buffer pH 8 solution was freshly prepared and 
adequately diluted in order to obtain the working solutions. 
The pharmaceutical samples were Tylenol (Janssen-Cilag 
Farmacêutica LTDA, Brazil), Resfenol (Kley Hertz S.A., 
Brazil), Buscopan Plus (Boehringer Ingelheim, Brazil) and 
Trimedal (Novartis Biociências S.A., Brazil).
Procedures for pharmaceutical formulation analysis
Accord ing  to  the  Braz i l i an  Pharmacopea 
recommendations,25 twenty tablets were weighed and 
powdered. Accurately weighed portions of powder 
equivalents to 750, 500 and 500 mg for Tylenol, Buscopan 
Figure 1. Scheme of the flow injection system with electrochemical 
detection used for the determination of APAP: S: sample, 5.00 x 10-3 mol 
L
-1
 APAP solution; Ca: carrier, universal buffer pH 8.0; D, waste; L, loop;
R, W, C, reference (Ag/AgCl), working (60%, graphite, m/m) and counter 
(platinum disk) electrodes, respectively; EC, electrochemical flow-through 
cell; Potentiostat, Autolab PGSTAT-30 potenciostate-galvanostate. In the 
detail a scheme of the EC used in the measurements in FIA system (1) 
Block of polyurethane resin, (2) polyethylene tube.
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Plus and Trimedal, respectively, and 40 mg of Resfenol 
solution were dissolved in 25 mL of universal buffer pH 8
to obtain solutions correspondent to 2.00 r 10-3 mol L-1
in APAP. The solutions were sonicated for 10 minutes to 
complete the dissolution.
Procedures for working electrode
The composite 60% (graphite, m/m) electrode was 
prepared as previously described.20 Briefly, adequate 
amounts of the polyol and hardener, in proportion of 
0.8 to 1 according to the manufacturer recommendation, 
and graphite (Aldrich, USA) were mixed in a mortar for 
5 min in order to obtain a mixture with 60% of graphite 
(m/m). The resulting mixture is inserted in a manual press 
and extruded as 3.0 mm diameter rods, with geometrical 
area 0.0707 cm2. The composite was cured for 24 h at 
room temperature and cutted in pieces with 1.0 cm long. 
A copper wire (F 1.0 mm) was attached to these rods 
with the help of a silver epoxy (EPO-TEK 410E, Epoxy 
Technology, USA), conducting resin in order to reach 
electric contact. This set was then inserted in an electrode 
body built up in PU resin, 5.0 mm i.d. (detail Figure 1) 
and sealed with the PU resin. A curing time of 24 h was 
adopted before use. Surface renewal was not necessary 
during the experiments as no APAP adsorption on the 
electrode surface was observed.
Flow injection measurements
The effect of different parameters relative to the flow 
system, such as carrier solution flow rate (1.4, 2.6, 3.9, 5.2, 
6.5 and 7.7 mL min-1), detection potential (400, 450, 500, 
550 and 600 mV vs. Ag/AgCl) and sample loop volume 
(25, 50, 75, 100, 126 and 151 µL) were evaluated. 
Before the measurements the composite electrode was 
placed in the voltammetric cell in contact with the carrier 
solution, flowing during 2 min. This showed to be enough 
to obtain a stable baseline.
Using the optimized conditions an analytical curve was 
obtained by injection of different concentrations of APAP, 
in increasing order from 5.00 r 10-5 to 5.00 r 10-3 mol L-1,
using the optimized parameters. The same procedure was 
repeated, but now in decreasing order to check if any 
memory effect was present. The injections were performed 
in quintuplicate, only for the standard solutions.
In the determination of APAP in pharmaceutical 
formulations, each standard APAP solution was injected 
three times in the increasing order from 5.00 r 10-5
to 3.00 r  10-3 mol L-1, after that, four samples of 
2.00 r  10-3 mol L-1 APAP content in pharmaceutical 
formulations (Tylenol, Resfenol, Buscopan Plus and 
Trimedal) were injected three times. Then, the same 
procedure was repeated, but now in decreasing order, for 
the standard solutions only.
Comparison method
The comparison method was realized according to 
the American Pharmacopea recommendations.26 Liquid 
chromatography (HPLC) were recorded in a Shimadzu 
SCL-10A VP chromatograph, equipped with a RP-18 
column (150 r 4.6 mm, 5 µm, Aldrich, USA). The detector 
used was an UV vis SPD-10A VP (Shimadzu, USA).
Results and Discussion
Flow injection parameters
The following parameter were optimized: the flow 
rate, a hydrodynamic factor which plays an important 
role in the efficiency of mass transport of analyte from 
bulk solution toward the electrode surface, being a major 
factor affecting the magnitude of peak currents in flow 
injection amperometry; the detection potential, which plays 
an important role in the selectivity and sensitivity of the 
analysis and the sample volume that defines the amount of 
analyte to be detected.
The effect of the flow rate on the peak current was 
evaluated between 1.4 and 7.7 mL min-1 by successive 
injections of 5.00 r 10-3 mol L-1APAP solution in universal 
buffer, pH 8 in which better sensitivity and peak resolution 
have been observed previously. The current increased 
continuously over the all range of flow rates investigated. 
Then 6.5 mL min-1 was chosen for further studies, since 
above this flow rate the increase in the current signal is 
not enough to justify the reagent consumption and waste 
generation. Additionally, for higher flow rates, the standard 
deviation is higher.
The effect of the detection potential was evaluated 
between 400 and 600 mV by successive injection of 
5.00 r 10-3 mol L-1 APAP solution. These values were 
chosen because in cyclic voltammetric the oxidation peak 
of APAP occurs in approximately 400 mV (Figure 2.a). 
The effect of the detection potential showed that there is 
no difference in the currents obtained at potential values 
higher than 500 mV, remaining practically constant (Figure 
2.b). Thus, 500 mV was chosen for further studies since 
it presented less standard deviation between successive 
measurements and lower risk of oxidizing other species.
The effect of the sample volume in the transient signals 
was investigated for volumes from 25 to 151 µL using a 
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5.00 r 10-3 mol L-1 APAP solution, under a flow rate of 
6.5 L min-1 and detection potential fixed at 500 mV. The 
current signal increased significantly up to 100 µL. For 
higher sample loop volumes the signal remained practically 
constant. So, this volume was selected.
Analytical curve 
The analytical curve (Figure 3) was obtained in order 
to evaluate the behavior of the amperometric response of 
the composite 60% (graphite, m/m) in comparison to the 
concentration of APAP.
Using the optimized conditions, a linear response 
was obtained in the 5.00 r 10-5 to 5.00 r 10-3 mol L-1
APAP concentration range (Figure 3). The observed 
linear region in all the analyzed range, follows the linear 
equation 1.
y= -0.35 µA + 8.8 mA mmol-1 L C
APAP
,
(n = 5, R =0.999) (1)
Analytical frequencies of 180 determinations per 
hour were observed under the optimized conditions. The 
limit of detection (LOD) obtained in this interval was 
of 18.9 µmol L-1, determined as three times the standard 
deviation of the blank (S
d
) divided by the angular coefficient 
of straight line (b)27
LOD = 3 S
d
 / b (2)
The LOD for APAP at a glassy carbon electrode with 
a geometrical area of 0.196 cm2, used as amperometric 
flow detector under the same experimental conditions 
for comparison was 108 Mmol L-1, i.e. six times higher, 
and it presented saturation at the electrode surface for 
concentrations values higher than 1.00 r 10-3 mol L-1.
A peak current of 32.1 ± 0.1 MA for 10 successive 
injections of a 5.00 r 10-3 mol L-1 APAP solutions under the 
optimized conditions were observed, a variance coefficient 
of 0.3%.
Determination of APAP in pharmaceutical formulations
The applicability of the composite electrode 60% 
(graphite, m/m) as a FIA amperometric detector for 
the determination of APAP was verified analyzing four 
pharmaceutical formulations as described previously. 
Figure 2. (a) Ciclic voltammogram of 1.00 x 10-3 mol L-1APAP solution 
using 60% (graphite, m/m) composite electrode in universal buffer pH 8, 
v = 25 mV s-1. (b) Effect of the detection potential in the amperometric 
response of a 1.00 r 10-3 mol L-1 APAP solution in the FIA system using 
an universal buffer solution pH 8.0 as carrier, 3.9 mL min-1 flow rate, 
50 µL sample loop, at the 60% (graphite, m/m) composite as working 
electrode.
Figure 3. Transient signals obtained at the composite 60% (graphite, 
m/m) electrode using (a) 5.00 r 10-5, (b) 1.00 r 10-4, (c) 5.00 r 10-4, (d) 
1.00 r 10-3 and (e) 5.00 r 10-3 mol L-1 of APAP and universal buffer pH 8 
as a carrier, flow rate of de 6.5 mL min-1, detection potential of 500 mV 
(vs. Ag/AgCl) and sample loop volume of 100 µL. In the detail the linear 
portion of the analytical curve.
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Figure 4 shows the transient signals obtained for standard 
and sample solutions, and the resulting analytical curve.
Table 1 presents the obtained results using the proposed 
flow procedure and the HPLC as a comparative method. The 
results agreed within 95% of confidence level according 
to the t-Student test.28
Interference study was carried out in order to investigate 
the effect of ascorbic acid on the amperometric response 
of APAP since some commercial formulations can contain 
both analytes. FIA experiments were carried out for 
5.00 r 10-4 mol L-1 APAP in presence of differentof ascorbic 
acid concentrations. Interference was represented as an 
increase of 10, 15 e 14% in the APAP current, respectively 
for 2.50, 5.00 and 10.0 r 10-4 mol L-1 of ascorbic acid.
One of the formulations analyzed (Trimedal) present 
both ascorbic acid and APAP. However, it was possible 
to determine APAP in the presence of AA even in this 
sample reaching results that agreed with those from 
chromatography, as observed in Table 1. This is probably 
related to the very low concentration of the interferant in 
the formulation, since the sample contains 500 mg of APAP 
and only 40 mg of AA.
As any interference was observed by the other 
components of the pharmaceutical formulations it might 
be possible that this procedure can be used for APAP 
quantification.
Conclusions
According to these results it can be concluded that 
the composite 60% (graphite, m/m) electrode represents 
an interesting alternative to be used in FIA for the 
determination of APAP with a detection limit in the 
µmol L-1 level without modification. The method has 
been satisfactorily applied to determination of APAP in 
pharmaceutical formulations.
Although lower detection limits can be found in the 
literature, the graphite-PU composite electrode is an 
inexpensive and long life device that can be used with any 
further modification. 
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